Print version of this report
TGA Action ID RC-2025-RN-00816-1
Type of Product Medical Device
Product Name/Description Alinity hq Analyser. An in vitro diagnostic medical device (IVD)

List Number 09P68-01

Serial Numbers HQ00204; HQ00208; HQ00654; HQ00922; HQ00932
ARTG Number 388425
Unique Device Identifier (UDI) (01)380740138851(21)HQ00204, (01)380740138851(21)HQ00208, (01)380740138851(21)HQ00654, (01)380740138851(21)HQ00922, (01)380740138851(21)HQ00932
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action In the Alinity hq Analyser software versions 5.0 to 5.10.1, the system does not visibly apply appropriate flagging when Immature Granulocyte (IG) Saturation is present.
This may prevent users from recognising potentially impacted values.

Any distortion in IG values may affect other parameters, potentially leading to inaccurate distribution across the full WBC differential.

There have been no customer complaints or adverse events reported.
Instructions for Customers/Users - Customers are advised to review the results if the IG/%IG is above their laboratory-established reference range. A manual smear review may need to be performed to confirm the results.

- A new software version for the Alinity hq Analyser to resolve this problem is expected to be available in 2026. An Abbott representative will contact affected customers to schedule a mandatory upgrade.

This action has been closed out on 22/09/2026
Action Commencement Date 24/09/2025
Responsible Entity Abbott Australasia Pty Ltd Diagnostic Division
Contact Information 1800 816 696 - Abbott Customer Support